HLA-C and neoplasm: The presentation of tumor-associated antigens must be degraded to short peptides by APCs, and then bound to major histocompatibility complex (MHC) molecules to form peptide-MHC-TCR complexes for recognition by T cells that stimulate the response of CTLs [12, 13].